Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J van Megen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|June 5, 2001
[Inadequate pharmacotherapy in patients with obsessive-compulsive disorder]D Denys, H J van Megen, H G Westenberg
Acta Neuropsychiatrica|March 10, 2016
Neuropeptides and anxiety disordersH J van Megen, J A den Boer, H G Westenberg
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 1, 1994
On the significance of cholecystokinin receptors in panic disorderH J van Megen, J A den Boer, H G Westenberg
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 1, 1996
The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorderH J van Megen, H G Westenberg, J A Den Boer, et al.
Psychopharmacology|January 7, 1999
Sumatriptan (5-HT1D receptor agonist) does not exacerbate symptoms in obsessive compulsive disorderK L Pian, H G Westenberg, H J van Megen, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 1, 1996
Cholecystokinin in anxietyH J van Megen, H G Westenberg, J A den Boer, et al.
Psychopharmacology|February 1, 1997
Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacksH J van Megen, H G Westenberg, J A den Boer, et al.
Psychopharmacology|April 1, 1994
Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patientsH J van Megen, H G Westenberg, J A den Boer, et al.
Psychopharmacology|August 13, 2002
Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memoryM W van Laar, E R Volkerts, M N Verbaten, et al.
Psychopharmacology|February 1, 1997
The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patientsH J van Megen, H G Westenberg, J A den Boer, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nederlands Tijdschrift Voor Geneeskunde|June 5, 2001
[Inadequate pharmacotherapy in patients with obsessive-compulsive disorder]D Denys, H J van Megen, H G Westenberg
Acta Neuropsychiatrica|March 10, 2016
Neuropeptides and anxiety disordersH J van Megen, J A den Boer, H G Westenberg
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 1, 1994
On the significance of cholecystokinin receptors in panic disorderH J van Megen, J A den Boer, H G Westenberg
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 1, 1996
The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorderH J van Megen, H G Westenberg, J A Den Boer, et al.
Psychopharmacology|January 7, 1999
Sumatriptan (5-HT1D receptor agonist) does not exacerbate symptoms in obsessive compulsive disorderK L Pian, H G Westenberg, H J van Megen, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 1, 1996
Cholecystokinin in anxietyH J van Megen, H G Westenberg, J A den Boer, et al.
Psychopharmacology|February 1, 1997
Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacksH J van Megen, H G Westenberg, J A den Boer, et al.
Psychopharmacology|April 1, 1994
Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patientsH J van Megen, H G Westenberg, J A den Boer, et al.
Psychopharmacology|August 13, 2002
Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memoryM W van Laar, E R Volkerts, M N Verbaten, et al.
Psychopharmacology|February 1, 1997
The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patientsH J van Megen, H G Westenberg, J A den Boer, et al.
Pageof 2